Atlas Trials

A Pharmacokinetic Study of DW6013 (FDC of Linagliptin and Metformin) in Healthy Adult Volunteers in Fed Condition

Clinical trial NCT05874180 · COMPLETED

Trial details

NCT number
NCT05874180
Sponsor
Dong Wha Pharmaceutical Co. Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Subjects
Start date
2023-01-09
Primary completion
2023-02-01
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.